Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

With an increasing number of diabetes patients needing care, and not enough healthcare professionals to adequately manage their chronic conditions, community pharmacists may be uniquely positioned to help fill these needs. ...

View Blog Post
Blog Post

As I write this blog, I am wrapping up participating in the annual meeting of one of my favorite organizations: The American Society of Automation in Pharmacy (ASAP). ...

View Blog Post
Blog Post

This is the last week for the public to submit comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up